French competition body fines Sanofi in Plavix dispute

PARIS (Reuters) - The French Competition Authority said on Tuesday it fined drugmaker Sanofi 40.6 million euros ($52.7 million) over what it called a smear campaign aimed at stifling generic competition to its blood thinner, Plavix.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news